Y101
metabolic profile
pharmacokinetics
species differences
toxicokinetics
Journal
Xenobiotica; the fate of foreign compounds in biological systems
ISSN: 1366-5928
Titre abrégé: Xenobiotica
Pays: England
ID NLM: 1306665
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
pubmed:
23
7
2019
medline:
1
4
2020
entrez:
23
7
2019
Statut:
ppublish
Résumé
The objective of this study was to clarify the species differences of pharmacokinetics of Y101 (N-[N-benzoyl-O-(2-dimethylaminoethyl)-l-tyrosyl]-l-phenylalaninol hydrochloride), a derivative of herbal ingredient with anti-HBV hepatitis activity, in rats, dogs, monkeys and humans.The metabolic stability and metabolite identification studies using liver microsomes
Identifiants
pubmed: 31329010
doi: 10.1080/00498254.2019.1646946
doi:
Substances chimiques
Antiviral Agents
0
Benzamides
0
Dipeptides
0
N-(N-benzoyl-O-(2-dimethylaminoethyl)tyrosyl)phenylalaninol
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM